If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKosmos Energy Regulatory News (KOS)

Share Price Information for Kosmos Energy (KOS)

Share Price is delayed by 15 minutes
Get Live Data
160.00    -1.50 (-0.93%)
Bid:
151.00
Ask:
169.00
Spread: 18.00 (11.921%)
Market Cap: £958.00m
KOS Live PriceLast checked at - London Stock Exchange

Intraday Kosmos Energy Share Chart

Director/PDMR Shareholding

Today 07:00

RNS Number : 2308L
Kosmos Energy Limited
07 July 2026
 

Kosmos Energy Ltd (the "Company")PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

07 July 2026

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:

PDMR

Date of transaction

No. of shares vested

No. of shares granted

No. of shares sold or withheld

Josh R. Marion

1 July 2026

0

64,248

0

Josh R. Marion

1 July 2026

64,248

0

0

Josh R. Marion

2 July 2026

0

0

24,969

Ronald W. Glass

1 July 2026

0

31,196

0

Ronald W. Glass

1 July 2026

31,196

0

0

Ronald W. Glass

2 July 2026

0

0

12,128

Andrew G. Inglis

1 July 2026

0

221,171

0

Andrew G. Inglis

1 July 2026

221,171

0

0

Andrew G. Inglis

2 July 2026

0

0

85,935

Neal D. Shah

1 July 2026

0

118,329

0

Neal D. Shah

1 July 2026

118,329

0

0

Neal D. Shah

2 July 2026

0

0

45,980

 

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Josh R. Marion

Corporate Secretary

CONTACT:

Investor Relations

Jamie Buckland +44 203 954 2831 jbuckland@kosmosenergy.comMedia Relations

Thomas Golembeski +1-214-445-9674 tgolembeski@kosmosenergy.com

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Josh R. Marion

b)

Position / status

SVP and General Counsel

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

64,248 restricted share units granted under the Plan which are scheduled to vest 100% on July 1, 2026, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

2.03

Volume

64,248

Total

130,423.44

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

2.03

Volume

64,248

Total

130,423.44

e)

Date of the transactions

1 July 2026

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

64,248 shares issued on settlement of restricted share units granted to the reporting person on 1 July 2026 under the Company's Long Term Incentive Plan (the "Plan") subject to the terms of the Plan and the applicable award agreement issued thereunder.

Shares Granted or Vested

c)

Currency

USD

Price

2.03

Volume

64,248

Total

130,423.44

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

2.03

Volume

64,248

Total

130,423.44

e)

Date of the transactions

1 July 2026

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

24,969 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

2.05

Volume

24,969

Total

51,186.45

d)

Aggregated information 

Price

2.05

Volume

24,969

Total

51,186.45

e)

Date of the transactions

2 July 2026

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Ronald W. Glass

b)

Position / status

Vice President and Chief Accounting Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

31,196 restricted share units granted under the Plan which are scheduled to vest 100% on July 1, 2026, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

2.03

Volume

31,196

Total

63,327.88

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

2.03

Volume

31,196

Total

63,327.88

e)

Date of the transactions

1 July 2026

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

31,196 shares issued on settlement of restricted share units granted to the reporting person on 1 July 2026 under the Company's Long Term Incentive Plan (the "Plan") subject to the terms of the Plan and the applicable award agreement issued thereunder.

Shares Granted or Vested

c)

Currency

USD

Price

2.03

Volume

31,196

Total

63,327.88

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

2.03

Volume

31,196

Total

63,327.88

e)

Date of the transactions

1 July 2026

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

12,128 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

2.05

Volume

12,128

Total

24,862.40

d)

Aggregated information 

Price

2.05

Volume

12,128

Total

24,862.40

e)

Date of the transactions

2 July 2026

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew G. Inglis

b)

Position / status

Chairman and Chief Executive Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

221,171 restricted share units granted under the Plan which are scheduled to vest 100% on July 1, 2026, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

2.03

Volume

221,171

Total

448,977.13

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

2.03

Volume

221,171

Total

448,977.13

e)

Date of the transactions

1 July 2026

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

221,171 shares issued on settlement of restricted share units granted to the reporting person on 1 July 2026 under the Company's Long Term Incentive Plan (the "Plan") subject to the terms of the Plan and the applicable award agreement issued thereunder.

Shares Granted or Vested

c)

Currency

USD

Price

2.03

Volume

221,171

Total

448,977.13

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

2.03

Volume

221,171

Total

448,977.13

e)

Date of the transactions

1 July 2026

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

85,935 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

2.05

Volume

85,935

Total

176,166.75

d)

Aggregated information 

Price

2.05

Volume

85,935

Total

176,166.75

e)

Date of the transactions

2 July 2026

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Neal D. Shah

b)

Position / status

Senior Vice President and Chief Financial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

118,329 restricted share units granted under the Plan which are scheduled to vest 100% on July 1, 2026, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

2.03

Volume

118,329

Total

240,207.87

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

2.03

Volume

118,329

Total

240,207.87

e)

Date of the transactions

1 July 2026

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

118,329 shares issued on settlement of restricted share units granted to the reporting person on 1 July 2026 under the Company's Long Term Incentive Plan (the "Plan") subject to the terms of the Plan and the applicable award agreement issued thereunder.

Shares Granted or Vested

c)

Currency

USD

Price

2.03

Volume

118,329

Total

240,207.87

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

2.03

Volume

118,329

Total

240,207.87

e)

Date of the transactions

1 July 2026

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

45,980 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

2.05

Volume

45,980

Total

94,259

d)

Aggregated information 

Price

2.05

Volume

45,980

Total

94,259

e)

Date of the transactions

2 July 2026

f)

Place of the transaction

NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSUEFMEMSEFW
Date   Source Headline
14th Apr 20204:36 pmRNSPrice Monitoring Extension
9th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20204:42 pmRNSSecond Price Monitoring Extn
8th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20201:30 pmRNSRBL Re-determination and Operational Update
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSOperational Update
16th Mar 20204:18 pmRNSDirector/PDMR Shareholding
13th Mar 20204:24 pmRNSDirector/PDMR Shareholding
11th Mar 20207:00 amRNSDirector/PDMR Shareholding
10th Mar 20204:40 pmRNSSecond Price Monitoring Extn
10th Mar 20204:35 pmRNSPrice Monitoring Extension
9th Mar 20203:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:52 pmRNSChief Financial Officer succession
2nd Mar 20207:00 amRNSInvestor presentation
24th Feb 20207:01 amRNSDividend Declaration
24th Feb 20207:00 amRNS4th Quarter and Full Year 2019 Results
24th Feb 20207:00 amRNSKosmos Energy Appoints New Chief Financial Officer
18th Feb 202010:30 amRNSLNG Sale and Purchase Agreement
12th Feb 20207:00 amRNSTortue Sale & Purchase Agreement Signed
12th Feb 20207:00 amRNSReserves Update
11th Feb 20204:35 pmRNSPrice Monitoring Extension
5th Feb 20207:00 amRNSDirector/PDMR Shareholding
29th Jan 20207:00 amRNSGulf of Mexico Drilling Update
27th Jan 20207:00 amRNSFourth Quarter 2019 Results February 24, 2020
9th Jan 20207:00 amRNSDirector/PDMR Shareholding
7th Jan 20207:00 amRNSDirector/PDMR Shareholding
29th Nov 20194:30 pmRNSDirectorate Change
26th Nov 20197:00 amRNSGulf of Mexico Drilling Update
14th Nov 20194:30 pmRNSReorganisation of certain management roles
11th Nov 20197:00 amRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSAppointment of Lisa Davis to Board of Directors
4th Nov 20197:00 amRNSDividend Declaration
4th Nov 20197:00 amRNS3rd Quarter Results
28th Oct 20197:00 amRNSMAJOR GAS DISCOVERY OFFSHORE MAURITANIA
8th Oct 201910:37 amRNSThird Quarter Results - November 4, 2019
23rd Sep 20197:00 amRNSYakaar-2 Confirms World-Scale Gas Resource
20th Sep 20197:00 amRNSDirectorate Change
15th Aug 20194:36 pmRNSPrice Monitoring Extension
9th Aug 20194:36 pmRNSPrice Monitoring Extension
6th Aug 20194:35 pmRNSPrice Monitoring Extension
5th Aug 20197:01 amRNSDividend Declaration
5th Aug 20197:00 amRNSSECOND QUARTER 2019 RESULTS
23rd Jul 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.